Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

[1]  S. Justice,et al.  Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. , 2010, Annual review of microbiology.

[2]  T. Miethke,et al.  Inhibition of TIR Domain Signaling by TcpC: MyD88-Dependent and Independent Effects on Escherichia coli Virulence , 2010, PLoS pathogens.

[3]  H. Mobley,et al.  Host–pathogen interactions in urinary tract infection , 2010, Nature Reviews Urology.

[4]  Matthew G. Blango,et al.  Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics , 2010, Antimicrobial Agents and Chemotherapy.

[5]  H. Mobley,et al.  Genomic Islands of Uropathogenic Escherichia coli Contribute to Virulence , 2009, Journal of bacteriology.

[6]  A. Ashkar,et al.  FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling , 2008, PLoS pathogens.

[7]  S. Hultgren,et al.  G‐CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity , 2008, Cellular microbiology.

[8]  A. Ashkar,et al.  Cutting Edge: FimH Adhesin of Type 1 Fimbriae Is a Novel TLR4 Ligand1 , 2008, The Journal of Immunology.

[9]  F. Tacke,et al.  CCR2 Mediates Homeostatic and Inflammatory Release of Gr1high Monocytes from the Bone Marrow, but Is Dispensable for Bladder Infiltration in Bacterial Urinary Tract Infection1 , 2008, The Journal of Immunology.

[10]  T. J. Wiles,et al.  Origins and virulence mechanisms of uropathogenic Escherichia coli. , 2008, Experimental and molecular pathology.

[11]  B. Dhakal,et al.  Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli , 2008, European journal of clinical investigation.

[12]  A. Wieser,et al.  Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins , 2008, Nature Medicine.

[13]  Kristen E Pascal,et al.  Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway. , 2008, Microbes and infection.

[14]  P. Humphrey,et al.  Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection , 2007, PLoS medicine.

[15]  S. Hultgren,et al.  Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract , 2006, Proceedings of the National Academy of Sciences.

[16]  E. Nielsen,et al.  Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. , 2006, FEMS microbiology letters.

[17]  J. Adams,et al.  Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.

[18]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[19]  Daniel R. Caffrey,et al.  Of mice and man: TLR11 (finally) finds profilin. , 2005, Trends in immunology.

[20]  G. Ulett,et al.  Nitric oxide is a key determinant of group B streptococcus-induced murine macrophage apoptosis. , 2005, The Journal of infectious diseases.

[21]  M. Greenblatt,et al.  A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria , 2004, Science.

[22]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[23]  M. Footer,et al.  Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Hultgren,et al.  Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.

[25]  S. Hultgren,et al.  Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Horton,et al.  Influence of Extracellular Bactericidal Agents on Bacteria within Macrophages , 2003, Infection and Immunity.

[27]  B. Foxman.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2003, Disease-a-month : DM.

[28]  F. Blattner,et al.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Ronald.  The etiology of urinary tract infection: traditional and emerging pathogens. , 2002, The American journal of medicine.

[30]  S. Hultgren,et al.  Establishment of a Persistent Escherichia coli Reservoir during the Acute Phase of a Bladder Infection , 2001, Infection and Immunity.

[31]  W. Stamm,et al.  Urinary tract infections: disease panorama and challenges. , 2001, The Journal of infectious diseases.

[32]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[33]  L. Hang,et al.  The ‘innate’ host response protects and damages the infected urinary tract , 2001, Annals of medicine.

[34]  E. Sokurenko,et al.  Functional Flexibility of the FimH Adhesin: Insights from a Random Mutant Library , 2000, Infection and Immunity.

[35]  M. Schembri,et al.  Bacterial adhesins: function and structure. , 2000, International journal of medical microbiology : IJMM.

[36]  D. Hume,et al.  Bacterial lipopolysaccharide confers resistance to G418, doxorubicin, and taxol in the murine macrophage cell line, RAW264 , 1996, Journal of leukocyte biology.

[37]  P. Campbell,et al.  Gentamicin kills intracellular Listeria monocytogenes , 1994, Infection and immunity.

[38]  N. Blau,et al.  Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. , 1993, The Journal of infectious diseases.

[39]  W. Stamm.  Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. , 1991, The American journal of medicine.

[40]  C. Svanborg,et al.  Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence , 1991, Infection and immunity.

[41]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[42]  P. Tynan,et al.  Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy , 1982, Cell.

[43]  M. Sweet,et al.  The role of monocytes and macrophages in innate immunity: macrophage anti-microbial pathways. , 2010 .